Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekPharmaVoice ↗
The red-hot market has plenty of room for additional therapies from big-name players and clinical-stage compan…
The WeekBioPharma Dive ↗
The acquisition by royalty management company Zymeworks follows a "strategic review" triggered by the failure …
The WeekFiercePharma ↗
As Amgen prepares to defend Tavneos' market approval in the U.S., the company has received a bad omen overseas…
The WeekFierceBiotech ↗
AstraZeneca has shared the data behind previously disclosed phase 3 rare disease wins, fleshing out the case f…
The WeekBriefing
STAT News flagged two developments: a congressional bill to revamp the 340B drug discount program and talk of …
The WeekDrug Channels ↗
Happy 250th birthday, America! Before you launch your semiquincentennial festivities, Drug Channels offers som…
The WeekSTAT News ↗
In a Q&A, Kenneth Chien, no longer with Moderna, predicts the company's mRNA cancer vaccine will be transforma…
The WeekFiercePharma ↗
Held just after the prestigious Cannes Film Festival in southern France, the Cannes Lions Festival of Creativi…
The WeekFierceBiotech ↗
Biogen isn't wasting any time integrating its multibillion-dollar purchase of Apellis, revealing plans to part…
The WeekBriefing
STAT reports that new technical advances in embryo genome editing are again stirring public and policy debate …
The WeekSTAT News ↗
The Supreme Court's ruling on Roundup shows science and law use the same word - causation - while asking diffe…
The WeekFiercePharma ↗
The agency spotted seven observations at Dr. Reddy's Bachupally, Hyderabad, biologics plant following a mid-Ju…
The WeekFierceBiotech ↗
As always, if you know of layoffs occurring at a biotech, please reach out to the Fierce Biotech editorial tea…
The WeekBriefing
The European Commission has launched formal antitrust proceedings into Sanofi’s flu vaccine marketing. The cas…
The WeekSTAT News ↗
What were the vibes like at BIO 2026? STAT reporters take you inside the annual industry conference on the lat…
The WeekAJMC ↗
Health Equity & Access Weekly Roundup: June 26, 2026…
The WeekBioPharma Dive ↗
Replimune's application is the latest example of changing attitudes at the FDA. Elsewhere, Revolution Medicine…
The WeekBioPharma Dive ↗
Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb …
The WeekBioPharma Dive ↗
Blair Jackson says the next 12 months may be the most important in Alkermes' history, as the brain drugmaker r…
The WeekPharmaVoice ↗
AI hasn't always been what it was cracked up to be in pharma. Here's where execs say the technology hasn't liv…
The WeekFiercePharma ↗
BeOne Medicines has extended its relationship with Blood Cancer United, committing $5 million over three years…
The WeekFierceBiotech ↗
Upon finally reaching the clinic, iBio feels vindicated about the artificial intelligence-powered discovery pl…
The WeekBriefing
Otsuka’s ADHD drug candidate met its Phase 3b endpoint in adults with comorbid anxiety, adding key data weeks …
The WeekDrug Channels ↗
Today's guest post comes from Geoffrey Chaiken and Matthew Chaiken, Co-founders of BlinkRx. Geoffrey and Matth…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.